These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 31126542)
1. Inhibitory effects of Cheongsangbangpoong-tang on both inflammatory acne lesion and facial heat in patients with acne vulgaris: A double-blinded randomized controlled trial. Kim B; Kim KI; Lee J; Kim K Complement Ther Med; 2019 Jun; 44():110-115. PubMed ID: 31126542 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of Cheongsangbangpoong-tang on both inflammatory acne lesions and facial heat in patients with acne vulgaris: A randomized controlled trial protocol. Kim K; Kim KI; Lee J BMC Complement Altern Med; 2016 Jan; 16():21. PubMed ID: 26800893 [TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory effect of Keigai-rengyo-to extract and acupuncture in male patients with acne vulgaris: a randomized controlled pilot trial. Kim KS; Kim YB J Altern Complement Med; 2012 May; 18(5):501-8. PubMed ID: 22594649 [TBL] [Abstract][Full Text] [Related]
4. Interaction and efficacy of Keigai-rengyo-to extract and acupuncture in male patients with acne vulgaris: a study protocol for a randomized controlled pilot trial. Kim KS; Kim YB Trials; 2011 Mar; 12():82. PubMed ID: 21418585 [TBL] [Abstract][Full Text] [Related]
5. Effects of herbal medicine for dysmenorrhea treatment on accompanied acne vulgaris: a study protocol for a randomized controlled trial. Kim KI; Nam HJ; Kim M; Lee J; Kim K BMC Complement Altern Med; 2017 Jun; 17(1):318. PubMed ID: 28623918 [TBL] [Abstract][Full Text] [Related]
6. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris. Lucky AW; Henderson TA; Olson WH; Robisch DM; Lebwohl M; Swinyer LJ J Am Acad Dermatol; 1997 Nov; 37(5 Pt 1):746-54. PubMed ID: 9366821 [TBL] [Abstract][Full Text] [Related]
7. Chinese herbal Pulian ointment in treating psoriasis vulgaris of blood-heat syndrome: a multi-center, double-blind, randomized, placebo-controlled trial. Li N; Zhao W; Xing J; Liu J; Zhang G; Zhang Y; Li Y; Liu W; Shi F; Bai Y BMC Complement Altern Med; 2017 May; 17(1):264. PubMed ID: 28506228 [TBL] [Abstract][Full Text] [Related]
8. A single-center, randomized double-blind, parallel-group study to examine the safety and efficacy of 3mg drospirenone/0.02 mg ethinyl estradiol compared with placebo in the treatment of moderate truncal acne vulgaris. Palli MB; Reyes-Habito CM; Lima XT; Kimball AB J Drugs Dermatol; 2013 Jun; 12(6):633-7. PubMed ID: 23839178 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of Modified Qufeng Runmian Powder () on Acne Vulgaris with Syndromes of Dampness and Blood Stasis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Zhang TB; Bai YP; Yang HY; Liu JL; Cao RQ; Wu ZH; Liu YC Chin J Integr Med; 2020 Jul; 26(7):490-496. PubMed ID: 32048170 [TBL] [Abstract][Full Text] [Related]
10. Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne. Ozolins M; Eady EA; Avery A; Cunliffe WJ; O'Neill C; Simpson NB; Williams HC Health Technol Assess; 2005 Jan; 9(1):iii-212. PubMed ID: 15588555 [TBL] [Abstract][Full Text] [Related]
11. A randomized, phase 2, dose-ranging study in the treatment of moderate to severe inflammatory facial acne vulgaris with doxycycline calcium. Leyden JJ; Bruce S; Lee CS; Ling M; Sheth PB; Stewart DM; Werschler WP; Gilbert RD; Kircik L J Drugs Dermatol; 2013 Jun; 12(6):658-63. PubMed ID: 23839182 [TBL] [Abstract][Full Text] [Related]
12. Results of a Phase 2, Randomized,Vehicle-Controlled Study Evaluating the Efficacy,Tolerability, and Safety of Daily or Twice Daily SB204 for the Treatment of Acne Vulgaris. Eichenfield LF; Gold LS; Nahm WK; Cook-Bolden FE; Pariser DM J Drugs Dermatol; 2016 Dec; 15(12):1496-15027. PubMed ID: 28095573 [TBL] [Abstract][Full Text] [Related]
13. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial. Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723 [TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy with methyl aminolaevulinate 80 mg g(-1) for severe facial acne vulgaris: a randomized vehicle-controlled study. Pariser DM; Eichenfield LF; Bukhalo M; Waterman G; Jarratt M; Br J Dermatol; 2016 Apr; 174(4):770-7. PubMed ID: 26663215 [TBL] [Abstract][Full Text] [Related]
15. Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled Study. Stein Gold L; Weiss J; Rueda MJ; Liu H; Tanghetti E Am J Clin Dermatol; 2016 Jun; 17(3):293-303. PubMed ID: 26945741 [TBL] [Abstract][Full Text] [Related]
16. Evaluating the Effects of Oral and Topical Simvastatin in the Treatment of Acne Vulgaris: A Double-blind, Randomized, Placebo-controlled Clinical Trial. Ahmadvand A; Yazdanfar A; Yasrebifar F; Mohammadi Y; Mahjub R; Mehrpooya M Curr Clin Pharmacol; 2018; 13(4):279-283. PubMed ID: 30129417 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Tazarotene 0.1% Plus Clindamycin 1% Gel Versus Adapalene 0.1% Plus Clindamycin 1% Gel in Facial Acne Vulgaris: A Randomized, Controlled Clinical Trial. Maiti R; Sirka CS; Ashique Rahman MA; Srinivasan A; Parida S; Hota D Clin Drug Investig; 2017 Nov; 37(11):1083-1091. PubMed ID: 28913735 [TBL] [Abstract][Full Text] [Related]
18. Topical methyl aminolaevulinate photodynamic therapy for treatment of facial acne vulgaris: results of a randomized, controlled study. Hörfelt C; Funk J; Frohm-Nilsson M; Wiegleb Edström D; Wennberg AM Br J Dermatol; 2006 Sep; 155(3):608-13. PubMed ID: 16911289 [TBL] [Abstract][Full Text] [Related]
19. Customized Single-agent Therapy Management of Severe Inflammatory Acne: A Randomized, Double-blind, Parallel-group, Controlled Study of a New Treatment--Adapalene 0.3%-Benzoyl Peroxide 2.5% Gel. Weiss J; Stein Gold L; Leoni M; Rueda MJ; Liu H; Tanghetti E J Drugs Dermatol; 2015 Dec; 14(12):1427-35. PubMed ID: 26659936 [TBL] [Abstract][Full Text] [Related]
20. The efficacy and safety of Danggui-Sayuk-Ga-Osuyu-Saenggang-tang on Korean patients with cold hypersensitivity in the hands: study protocol for a pilot, double-blind, randomized, placebo-controlled, parallel-group clinical trial. Ko Y; Go HY; Cho YY; Shin JH; Kim TH; Choi DJ; Lee JM; Jang JB; Song YK; Ko SG; Sun SH; Jeon CY Trials; 2017 Jun; 18(1):268. PubMed ID: 28595610 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]